Xpert MTB/XDR implementation in South Africa: cost outcomes of centralised vs. decentralised approaches
INTRODUCTION: In South Africa, Xpert® MTB/RIF Ultra (Ultra) is the recommended diagnostic assay for TB with line-probe assays for first- (LPAfl) and second-line drugs (LPAsl) providing additional drug susceptibility testing (DST) for samples that were rifampicin-resistant (RR-TB). To guide implement...
Saved in:
| Main Authors: | N. Cassim, S.V. Omar, S.D. Masuku, H. Moultrie, W.S. Stevens, F. Ismail, P. da Silva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2024-05-01
|
| Series: | IJTLD Open |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergy of Xpert (MTB/RIF) and Line probe assay for detection of rifampicin resistant strains of Mycobacterium tuberculosis
by: Shahida Hussain, et al.
Published: (2024-08-01) -
Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study
by: Jinsoo Min, et al.
Published: (2025-01-01) -
Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
by: Sahjid Mukhida, et al.
Published: (2022-01-01) -
XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01) -
Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)